This is a preview of subscription content, log in via an institution to check access.
References
Li LS, Liu ZH (2004) Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int 66(3):920
Jindal KK (1999) Management of idiopathic crescentic and diffuse proliferative glomerulonephritis: evidence-based recommendations. Kidney Int Suppl 70:S33–S40
Lv J, Yang Y, Zhang H et al (2013) Prediction of outcomes in crescentic IgA nephropathy in a multicenter cohort study. JASN 24(12):2118–2125
Tumlin JA, Lohavichan V, Hennigar R (2003) Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide. Nephrol Dial Transplant 18(7):1321–1329
Funding
The study did not receive any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors including Ramachandran R, Doddi P, Nandakrishna B, Nada R, Rathi M, Kohli HS, Jha V, Sakhuja V, Gupta KL have no conflict of interest to declare.
Ethical approval
The study was approved by the Institute Ethics Committee. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
A written informed consent was obtained from all individual participants included in the study.
Additional information
R. Ramachandran, P. Doddi and B. Nandakrishna equally contributed as first author.
Rights and permissions
About this article
Cite this article
Ramachandran, R., Doddi, P., Nandakrishna, B. et al. Combination of pulse cyclophosphamide and steroids in crescentic IgA nephropathy. Int Urol Nephrol 47, 1917–1918 (2015). https://doi.org/10.1007/s11255-015-1076-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-015-1076-z